<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">JCI Insight</journal-id>
<journal-id journal-id-type="iso-abbrev">JCI Insight</journal-id>
<journal-id journal-id-type="publisher-id">JCI Insight</journal-id>
<journal-title-group>
<journal-title>JCI Insight</journal-title>
</journal-title-group>
<issn pub-type="epub">2379-3708</issn>
<publisher>
<publisher-name>American Society for Clinical Investigation</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27517095</article-id>
<article-id pub-id-type="pmc">4978187</article-id>
<article-id pub-id-type="publisher-id">87168</article-id>
<article-id pub-id-type="doi">10.1172/jci.insight.87168</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Antiinflammatory effects of bromodomain and extraterminal domain inhibition in cystic fibrosis lung inflammation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Kong</given-names>
</name>
<email>kong.chen2@chp.edu</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Campfield</surname>
<given-names>Brian T.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wenzel</surname>
<given-names>Sally E.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McAleer</surname>
<given-names>Jeremy P.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kreindler</surname>
<given-names>James L.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kurland</surname>
<given-names>Geoffrey</given-names>
</name>
<email>Geoffrey.Kurland@chp.edu</email>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gopal</surname>
<given-names>Radha</given-names>
</name>
<email>radha.gopal4@chp.edu</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Ting</given-names>
</name>
<email>ting.wang5@chp.edu</email>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Wei</given-names>
</name>
<email>wei.chen@chp.edu</email>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eddens</surname>
<given-names>Taylor</given-names>
</name>
<email>taylor.eddens@chp.edu</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Quinn</surname>
<given-names>Kathleen M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Myerburg</surname>
<given-names>Mike M.</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Horne</surname>
<given-names>William T.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lora</surname>
<given-names>Jose M.</given-names>
</name>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Albrecht</surname>
<given-names>Brian K.</given-names>
</name>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pilewski</surname>
<given-names>Joseph M.</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kolls</surname>
<given-names>Jay K.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Richard King Mellon Foundation Institute for Pediatric Research, Children’s Hospital of Pittsburgh of University of Pittsburgh Medical Center (UPMC),</aff>
<aff id="A2"><label>2</label>University of Pittsburgh, Division of Pediatric Infectious Diseases, Department of Pediatrics,</aff>
<aff id="A3"><label>3</label>University of Pittsburgh Asthma Institute at UPMC, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.</aff>
<aff id="A4"><label>4</label>Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.</aff>
<aff id="A5"><label>5</label>Division of Pediatric Pulmonology, Children’s Hospital of Pittsburgh of UPMC,</aff>
<aff id="A6"><label>6</label>Division of Pulmonary Medicine, Children’s Hospital of Pittsburgh of UPMC, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.</aff>
<aff id="A7"><label>7</label>Division of Pulmonary, Allergy, and Critical Care Medicine, UPMC, Pittsburgh, Pennsylvania, USA.</aff>
<aff id="A8"><label>8</label>Constellation Pharmaceuticals Inc., Cambridge, Massachusetts, USA.</aff>
<author-notes>
<corresp>Address correspondence to: Jay K. Kolls, Department of Pediatrics, Children’s Hospital of Pittsburgh of University of Pittsburgh Medical Center, Rangos Research Building, 4401 Penn Avenue, Pittsburgh, Pennsylvania 15224, USA. Phone: 412.692.7710; E-mail: <email>Jay.Kolls@chp.edu</email>.</corresp>
</author-notes>
<pub-date date-type="pub" iso-8601-date="2016-07-21" publication-format="electronic">
<day>21</day>
<month>7</month>
<year>2016</year>
</pub-date>
<pub-date date-type="collection" iso-8601-date="2016-07-21" publication-format="electronic">
<day>21</day>
<month>7</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>21</day>
<month>7</month>
<year>2016</year>
</pub-date>
<!-- PMC Release delay is 0 months and
						0 days and was based on the <pub-date
						pub-type="epub"/>. -->
<volume>1</volume>
<issue>11</issue>
<elocation-id>e87168</elocation-id>
<history>
<date date-type="received">
<day>18</day>
<month>2</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>31</day>
<month>5</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2016, American Society for Clinical Investigation</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>American Society for Clinical Investigation</copyright-holder>
</permissions>
<self-uri xlink:href="https://insight.jci.org/articles/view/87168">This article is available online at https://insight.jci.org/articles/view/87168</self-uri>
<abstract>
<p>Significant morbidity in cystic fibrosis (CF) results from chronic lung inflammation, most commonly due to <italic>Pseudomonas aeruginosa</italic> infection. Recent data suggest that IL-17 contributes to pathological inflammation in the setting of abnormal mucosal immunity, and type 17 immunity–driven inflammatory responses may represent a target to block aberrant inflammation in CF. Indeed, transcriptomic analysis of the airway epithelium from CF patients undergoing clinical bronchoscopy revealed upregulation of IL-17 downstream signature genes, implicating a substantial contribution of IL-17–mediated immunity in CF lungs. Bromodomain and extraterminal domain (BET) chromatin modulators can regulate T cell responses, specifically Th17-mediated inflammation, by mechanisms that include bromodomain-dependent inhibition of acetylated histones at the <italic>IL17</italic> locus. Here, we show that, in vitro<italic>,</italic> BET inhibition potently suppressed Th17 cell responses in explanted CF tissue and inhibited IL-17–driven chemokine production in human bronchial epithelial cells. In an acute <italic>P</italic>. <italic>aeruginosa</italic> lung infection murine model, BET inhibition decreased inflammation, without exacerbating infection, suggesting that BET inhibition may be a potential therapeutic target in patients with CF.</p>
</abstract>
<abstract abstract-type="toc">
<p>Coordinated regulation of lung inflammation in cystic fibrosis requires bromodomain and extraterminal domain (BET) chromatin modulators.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>